I’m 63 and diagnosed with lymphoma. Should I take my Social Security next year?
“My plan is to continue working as long as I’m able to do so and invest my Social Security benefits while I’m still earning a paycheck.”
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by MarketWatch Top; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories
Why it mattersTesla’s newly unveiled flying sports car, which features SpaceX rocket thrusters, could help Musk push for a merger between his two biggest companies, analysts say,
By Michael·1h ago
Why it mattersSpending all your cash first can make your income surge in later years.
By Michael·1h ago'/> </pattern> </defs> <rect width='1200' height='675' fill='url(%23g)'/> <rect width='1200' height='675' fill='url(%23dots)'/> <rect x='60' y='210' width='6' height='80' fill='%23f5a524'/> <text x='90' y='268' font-size='15' font-weight='900' letter-spacing='5' fill='%23f5a524'>MARKETS</text> <g font-family='Inter, Arial, sans-serif'> <text x='60' y='320' font-size='44' font-weight='800' fill='rgba(255,255,255,0.97)' letter-spacing='-0.5'>¿Por qué el frenesí de deuda por la IA</text><text x='60' y='376' font-size='44' font-weight='800' fill='rgba(255,255,255,0.97)' letter-spacing='-0.5'>inquieta a los mercados?</text> <text x='60' y='620' font-size='14' font-weight='700' letter-spacing='3' fill='rgba(255,255,255,0.7)'>BLOOMBERG MARKETS · NEWSEZE</text> </g> </svg>)
Why it mattersLos CDS de Microsoft, Nvidia, Meta y Amazon se han disparado desde 2025. Wall Street empieza a preguntarse si el auge de la IA justificará la enorme deuda acumulada.
By Michael·54m ago'/> </pattern> </defs> <rect width='1200' height='675' fill='url(%23g)'/> <rect width='1200' height='675' fill='url(%23dots)'/> <rect x='60' y='210' width='6' height='80' fill='%23f5a524'/> <text x='90' y='268' font-size='15' font-weight='900' letter-spacing='5' fill='%23f5a524'>MARKETS</text> <g font-family='Inter, Arial, sans-serif'> <text x='60' y='320' font-size='44' font-weight='800' fill='rgba(255,255,255,0.97)' letter-spacing='-0.5'>City Therapeutics Raises $200 Million</text><text x='60' y='376' font-size='44' font-weight='800' fill='rgba(255,255,255,0.97)' letter-spacing='-0.5'>in Upsized US IPO</text> <text x='60' y='620' font-size='14' font-weight='700' letter-spacing='3' fill='rgba(255,255,255,0.7)'>BLOOMBERG MARKETS · NEWSEZE</text> </g> </svg>)
Why it mattersCity Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.
By Michael·15h ago